| Direct proinflammatory effect of C-reactive protein on human endothelial cells V Pasceri, JT Willerson, ETH Yeh Circulation 102 (18), 2165-2168, 2000 | 3397 | 2000 |
| Modulation of C-reactive protein–mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs V Pasceri, J Chang, JT Willerson, ETH Yeh Circulation 103 (21), 2531-2534, 2001 | 1456 | 2001 |
| Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA … G Patti, G Colonna, V Pasceri, LL Pepe, A Montinaro, G Di Sciascio Circulation 111 (16), 2099-2106, 2005 | 951 | 2005 |
| Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction … G Patti, M Chello, D Candura, V Pasceri, A D’Ambrosio, E Covino, ... Circulation 114 (14), 1455-1461, 2006 | 907 | 2006 |
| Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized … G Patti, V Pasceri, G Colonna, M Miglionico, D Fischetti, G Sardella, ... Journal of the American College of Cardiology 49 (12), 1272-1278, 2007 | 819 | 2007 |
| Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator–activated receptor-γ activators V Pasceri, HD Wu, JT Willerson, ETH Yeh Circulation 101 (3), 235-238, 2000 | 752 | 2000 |
| Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage … V Pasceri, G Patti, A Nusca, C Pristipino, G Richichi, G Di Sciascio Circulation 110 (6), 674-678, 2004 | 729 | 2004 |
| Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction … G Di Sciascio, G Patti, V Pasceri, A Gaspardone, G Colonna, A Montinaro Journal of the American College of Cardiology 54 (6), 558-565, 2009 | 617 | 2009 |
| A tale of two diseases: atherosclerosis and rheumatoid arthritis V Pasceri, ETH Yeh Circulation 100 (21), 2124-2126, 1999 | 612 | 1999 |
| Association of Virulent Helicobacter pylori Strains With Ischemic Heart Disease V Pasceri, G Cammarota, G Patti, L Cuoco, A Gasbarrini, RL Grillo, ... Circulation 97 (17), 1675-1679, 1998 | 512 | 1998 |
| C-reactive protein: linking inflammation to cardiovascular complications ETH Yeh, HV Anderson, V Pasceri, JT Willerson Circulation 104 (9), 974-975, 2001 | 451 | 2001 |
| Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention G Patti, A Nusca, M Chello, V Pasceri, A D’Ambrosio, GW Vetrovec, ... The American journal of cardiology 101 (3), 279-285, 2008 | 319 | 2008 |
| Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction F Andreotti, V Pasceri, DR Hackett, GJ Davies, AW Haider, A Maseri New England Journal of Medicine 334 (1), 7-12, 1996 | 319 | 1996 |
| Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation G Patti, V Pasceri, R Melfi, C Goffredo, M Chello, A D’Ambrosio, ... Circulation 111 (1), 70-75, 2005 | 265 | 2005 |
| Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies G Patti, CP Cannon, SA Murphy, S Mega, V Pasceri, C Briguori, ... Circulation 123 (15), 1622-1632, 2011 | 263 | 2011 |
| Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention … G Patti, E Ricottini, A Nusca, G Colonna, V Pasceri, A D'Ambrosio, ... The American journal of cardiology 108 (1), 1-7, 2011 | 260 | 2011 |
| Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials G De Luca, MT Dirksen, C Spaulding, H Kelbaek, M Schalij, L Thuesen, ... Archives of internal medicine 172 (8), 611-621, 2012 | 239 | 2012 |
| Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X GA Lanza, G Colonna, V Pasceri, A Maseri American Journal of Cardiology 84 (7), 854-856, 1999 | 230 | 1999 |
| Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the … G Patti, M Chello, V Pasceri, D Colonna, A Nusca, M Miglionico, ... Journal of the American College of Cardiology 48 (8), 1560-1566, 2006 | 212 | 2006 |
| Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction V Pasceri, G Patti, G Speciale, C Pristipino, G Richichi, G Di Sciascio American heart journal 153 (5), 749-754, 2007 | 178 | 2007 |
